Åsa Petersén
81 – 90 of 118
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Hippocampal cytogenesis is increased in a genetic rat model of depression. Escitalopram reduces increased cell number
2008) 21st Congress of the European-College-of-Neuropsychopharmacology In European Neuropsychopharmacology 18(S4). p.323-323(
- Contribution to journal › Published meeting abstract
-
Mark
Escitalopram reduces increased hippocampal cytogenesis in a genetic rat depression model.
(
- Contribution to journal › Article
-
Mark
Islet beta-cell area and hormone expression are unaltered in Huntington's disease.
(
- Contribution to journal › Article
- 2007
-
Mark
Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder.
(
- Contribution to journal › Article
-
Mark
Orexin and psychiatric symptoms in suicide attempters.
(
- Contribution to journal › Article
-
Mark
Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates
(
- Contribution to journal › Article
-
Mark
Cocaine- and amphetamine-regulated transcript is increased in Huntington disease.
(
- Contribution to journal › Article
-
Mark
Testicular degeneration in Huntington disease
(
- Contribution to journal › Article
- 2006
-
Mark
Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.
(
- Contribution to journal › Letter
-
Mark
Normal sensitivity to excitotoxicity in a transgenic Huntington's disease rat
(
- Contribution to journal › Article